MedTech Innovation

Q: 如果MedTech Innovation在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載MedTech Innovation。

Q: 運行MedTech Innovation的最低配置要求是什麼？

以下為MedTech Innovation的最低配置要求。<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

Free

5.4for iPhone, iPad

Rapid News

Developer

2017年12月19日

Update Date

Medical

Category

APKPure

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

MedTech Innovation 螢幕截圖

iPad

iPhone

About MedTech Innovation

Med-Tech Innovation News is the UK and Ireland's leading publication for medical design and manufacturing technology and innovation. It delivers daily news, technical content, analysis, case studies and high-profile interviews with industry experts and thought leaders.
Med-Tech Innovation News provides intelligence for professionals involved in the design and production of Class I, II & III medical devices and connects designers, manufacturers, buyers and early adopters across the medical engineering and manufacturing community with the latest innovations in technology, materials, processes, digital health and R&D.